Selection of rifampicin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin
Article first published online: 2 JUN 2009
1997 European Society of Clinical Microbiology and Infectious Diseases
Clinical Microbiology and Infection
Volume 3, Issue 1, pages 147–151, February 1997
How to Cite
Soro, O., Pesce, A., Raggi, M., Debbia, E. A. and Schito, G. C. (1997), Selection of rifampicin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin. Clinical Microbiology and Infection, 3: 147–151. doi: 10.1111/j.1469-0691.1997.tb00272.x
- Issue published online: 2 JUN 2009
- Article first published online: 2 JUN 2009
- 5Rifaximin in the treatment of hepatic encephalopathy. Eur J Clin Res 1993; 4: 57–66., , , , .
- 6Double-blind clinical trial on infectious diarrhoea therapy: rifaximin versus placebo. Curr Ther Res 1984; 36: 92–9., , , et al.
- 10Treatment of hepatic encephalopathy with L/105, a new non-absorbable rifamycin. Drugs Exp Clin Res 1984; 10: 691–6., , .
- 11Antibiotics and chemotherapy. New York : Churchill Livingstone, 1989: 217–37., , , .
- 13Antimicrobial agents and susceptibility tests: mycobacteria. In MurrayPR, BaronEJ, PfallerMA, TenoverFC, YolkenRH eds. Manual of clinical microbiology; Washington , DC : American Society of Microbiology, 1995: 1385–404., .
- 15National Committee for Clinical Laboratory Standards. Antimycobacterial susceptibility testing. Proposed standard M24-P, Vol. 10 No. 10. Villanova , PA : NCCLS, 1990.
- 16Bacterial resistance: theoretical and practical considerations, mutations to antibiotic resistance, characterization of R plasmid, and detection of plasmid-specific genes. In LorianV, ed. Antibiotics in laboratory medicine. Baltimore : Williams and Wilkins, 1991: 556–98., .